With an increase in utilizing serum concentrations of prostate specific antigen (PSA) for screening and early detection of PCa over the past two decades, a significant increase in the detection of low-grade prostate cancers has been observed. This evidence concerns the gene KLK3 and posterior cortical atrophy.